Pérez DJA, Aguilar AO, González CJC, Escandell RA, Leyva CR, Rodríguez PMM

Language: Spanish
References: 7
Page: 543-551
PDF size: 118.81 Kb.

ABSTRACT

Introduction: tricuspid valve infectious endocarditis (IE) is rare and is associated with older patients, intravenous drug users or patients requiring intracardiac devices, catheters or prostheses, human immunodeficiency virus infection, diabetes mellitus (DM), neoplasms and hemodialysis.
Case presentation: a case report of a 31-year-old woman with a history of health, who was admitted for prolonged febrile syndrome and anemia under study, is described; On admission, signs of heart failure were found, predominantly right, with arterial hypertension and diabetes mellitus onset.
Discussion: tricuspid valve infective endocarditis was confirmed by Staphylococcus aureus. Serious complications such as: heart failure, recurrent bacterial bronchopneumonia due to pulmonary septic emboli, acute renal failure due to acute glomerulonephritis and acute tubular necrosis; Hemolytic anemia and acute neuroretinitis due to vasculitis or septic brain embolus characterized its torpid evolution. It required hemodynamic support and successful cardiopulmonary resuscitation after multiple cardiorespiratory stops due to polymorphic sustained ventricular tachycardia and ventricular fibrillation due to severe internal environment disorders and sepsis. Ampicillin 12 grm/day e.v + rifampicin 600 mg/day v.o for 6 weeks, was effective in eliminating septicemia.
Conclusions: surgical treatment was applied (valvular replacement by metallic tricuspid prosthesis) without complications.

REFERENCES

1. Castillo JC, Anguita MP, Torres F, SilesJR, MesaD, Vallés F. Factores de riesgo asociados a endocarditis sin cardiopatías predisponentes. Rev Esp Cardiol2002; 55(3): 304-307.

2. Thomas J. Cahill, Larry M. Baddour, Gilbert Habib, Bruno Hoen. Challenges in Infective Endocarditis. J Am Coll Cardiol 2017; 69(3): 325-344.

3. Leyva QuertI AY, Ruiz Camejo T, González Corrig M, Peralta TM, Emperador CR, Gómez JA. Perfil clínico, epidemiológico y microbiológico de la endocarditis infecciosa en el Hospital "Hermanos Ameijeiras", 2005-2008. Rev Cub Med 2009; 48(3):1-14.

4. Shah PM. Valvulopatías tricúspidea y pulmonar: evaluación y tratamiento. Rev Esp Cardiol. 2010; 63(11): 1349–65.

5. Revilla A, López J, Villacorta E, Gómez I, Sevilla T, Del Pozo MA, et al. Endocarditis derecha aislada en pacientes no adictos a drogas por vía parenteral. Rev Esp Cardiol. 2008; 61(12): 1253–9.

6. Peña Irún A, González Santamaría AR. Endocarditis sobre válvula tricúspide secundaria a celulitis. Semergen 2014; 40(7): 355-414.

7. Carrillo-Esper R, Rangel-Olascoaga CR. Endocarditis tricuspídea. Med Int Méx 2014; 30(2): 209-214.